GC Cell's latest marketcap:
As of 08/02/2025, GC Cell's market capitalization has reached $210.13 M. According to our data, GC Cell is the 19986th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 210.13 M |
| Revenue (ttm) | 124.51 M |
| Net Income (ttm) | -59,220,206.93 |
| Shares Out | 15.03 M |
| EPS (ttm) | -3.94 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/27/2023 |
| Earnings Date | 08/14/2025 |
GC Cell's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | ₩291.83 B | $210.13 M | -14.77% | 19986 |
| 12/30/2024 | ₩356.14 B | $238.62 M | -47.9% | 17877 |
| 12/28/2023 | ₩683.53 B | $526.32 M | -3.46% | 12628 |
| 12/29/2022 | ₩708.04 B | $559.35 M | -55.94% | 11554 |
| 12/30/2021 | ₩1.61 T | $1.35 B | 65.31% | 7788 |
| 12/30/2020 | ₩972.03 B | $894.27 M | 143.01% | 8491 |
| 12/30/2019 | ₩400 B | $344 M | -17.43% | 11989 |
| 12/28/2018 | ₩484.43 B | $431.14 M | -8.2% | 9865 |
| 12/28/2017 | ₩527.7 B | $490.76 M | 100.4% | 10511 |
| 12/29/2016 | ₩263.32 B | $215.93 M | 12495 |
Company Profile
About GC Cell Corporation
GC Cell Corporation is a biotechnology company specializing in the development of innovative cell therapy products. The company is dedicated to advancing regenerative medicine through cutting-edge research and strategic collaborations.
Core Services
- Development of cell therapy products
- Cell banking services
- Sample inspection and clinical trial support
- Bio logistics solutions
Flagship Product
The company's leading product is Immuncell-LC, a key therapeutic solution in its portfolio.
Strategic Partnerships
GC Cell Corporation has entered into a strategic agreement with Lukas Biomedical Co., Ltd. to collaborate on the development of advanced cell therapies.
Corporate Background
Originally established as Green Cross Lab Cell Corporation in 2011, the company rebranded to GC Cell Corporation in November 2021. It is headquartered in Yongin-si, South Korea.
Frequently Asked Questions
-
What is GC Cell's (KOSDAQ-144510) current market cap?As of 08/02/2025, GC Cell (including the parent company, if applicable) has an estimated market capitalization of $210.13 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does GC Cell (KOSDAQ-144510) rank globally by market cap?GC Cell global market capitalization ranking is approximately 19986 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.